Skip to main content
NOVAREX Co., Ltd. logo

NOVAREX Co., Ltd. — Investor Relations & Filings

Ticker · 194700 ISIN · KR7194700001 KO Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2021-03-09 AGM Information
Country KR South Korea
Listing KO 194700

About NOVAREX Co., Ltd.

https://www.novarex.co.kr/en/

NOVAREX Co., Ltd. is a research and development-driven company specializing in health functional foods and supplements. It operates as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM), offering end-to-end services that encompass product planning, development, manufacturing, and delivery. Through its Life Science Research Center, the company develops novel functional ingredients validated by thorough verification and human application testing. NOVAREX manufactures a diverse range of product formulations, including tablets, capsules, powders, and stick jellies. A key competitive advantage is its extensive portfolio of individually recognized raw materials, underscoring its focus on scientific innovation and quality.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Novarex. It outlines the date, location, agenda items (such as financial statement approval, dividend approval, and director appointments), and board resolution details. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2021-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Novarex Co., Ltd. It contains the meeting agenda, date, location, and detailed information regarding board activities, remuneration, and business reports to be presented at the meeting. This document is a formal proxy statement and meeting notice sent to shareholders to solicit their attendance and votes, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2021-03-09 Korean
본점소재지변경
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details such as the old address, new address, reason for change, and the date of the board resolution. Since this is a standard corporate regulatory disclosure that does not fit into specific categories like financial reports, dividends, or M&A, it is classified as a general regulatory filing.
2021-03-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the change in share ownership (disposal of shares) by an executive (Min Bok-kee) of Novarex Co., Ltd. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it documents insider transactions by company management.
2021-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Novarex) announcing a significant change (over 30%) in revenue and profit structure. This is a standard 'Earnings Release' (ER) format used in the Korean market (DART system) to provide preliminary financial highlights before the final audited annual report is published. It contains key financial metrics, reasons for the change, and a disclaimer that it is subject to audit. FY 2020
2021-02-09 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.